The new indication for rosuvastatin is unlikely to have any significant impact on clinical practices because of questions about its clinical utility. Recently, the US Food and Drug Administration (FDA ...

Rosuvastatin for cholesterol lowering was associated with slightly greater risks for kidney harm than atorvastatin, risks that were greater at higher-dose levels, in a large retrospective cohort study ...

Two widely used statins, rosuvastatin and atorvastatin, are equally effective at preventing heart attacks, strokes and death in people with coronary artery disease. But while rosuvastatin treatment is ...

Two high-intensity statin regimens showed similar clinical efficacy when directly compared in secondary prevention, but one was associated with a greater risk of diabetes and cataracts in results from ...

Efficacy of switching statin therapy from generic simvastatin was examined in a VA population. Ezetimibe/simvastatin was more potent than atorvastatin or rosuvastatin in lowering LDL. Treatment of ...

NEW ORLEANS (Reuters) - AstraZeneca Plc's cholesterol drug Crestor significantly slowed build-up of plaque in the main artery supplying blood to the brain compared with a placebo in a two-year study ...

A head-to-head comparison of two popular lipid-lowering medications suggests that rosuvastatin may be a better option than atorvastatin when it comes to decreasing the risk of all-cause mortality and ...